Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre study.

ABSTRACT:

Objective

To report real-world rates of non-muscle-invasive bladder cancer (NMIBC) recurrence and progression within a European multicentre cohort with detailed information on intravesical instillation courses, as contemporary data on oncological outcomes in NMIBC are limited.

Patients and methods

A total of 1918 patients with NMIBC treated with transurethral resection of bladder tumour (TURBT) were retrospectively identified from six tertiary-referral European centres (2015-2022). Patients were stratified according to European Association of Urology 2021 criteria into low- (LR), intermediate- (IR), high- (HR) and very high-risk (VHR) categories. Cumulative incidence plots and multivariable competing risks regression models addressing 5-year rates of high-grade (HG) recurren

SUBMITTER: Longoni M 

PROVIDER: S-EPMC12522524 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature